Dr. Pomilla Kumar, M.D

NPI: 1568431880
Total Payments
$9,924
2024 Payments
$1,103
Companies
59
Transactions
618
Medicare Patients
1,974
Medicare Billing
$223,401

Payment Breakdown by Category

Food & Beverage$9,902 (99.8%)
Education$22.43 (0.2%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $9,902 613 99.8%
Education $22.43 5 0.2%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $1,198 68 $0 (2024)
Novo Nordisk Inc $1,051 72 $0 (2024)
PFIZER INC. $705.52 47 $0 (2024)
ABBVIE INC. $554.11 35 $0 (2024)
Otsuka America Pharmaceutical, Inc. $522.04 24 $0 (2024)
Novartis Pharmaceuticals Corporation $471.51 29 $0 (2024)
Janssen Pharmaceuticals, Inc $442.18 32 $0 (2024)
Lilly USA, LLC $435.04 29 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $422.99 29 $0 (2024)
Allergan, Inc. $385.63 27 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,103 50 Otsuka America Pharmaceutical, Inc. ($225.28)
2023 $1,217 64 AstraZeneca Pharmaceuticals LP ($161.38)
2022 $1,228 70 Otsuka America Pharmaceutical, Inc. ($144.20)
2021 $1,653 104 AbbVie Inc. ($356.84)
2020 $1,289 83 AstraZeneca Pharmaceuticals LP ($234.73)
2019 $988.35 65 Allergan Inc. ($122.57)
2018 $1,521 112 Novo Nordisk Inc ($254.87)
2017 $924.57 70 Novo Nordisk Inc ($161.96)

All Payment Transactions

618 individual payment records from CMS Open Payments — Page 1 of 25

Date Company Product Nature Form Amount Type
12/19/2024 Inspire Medical Systems, Inc. INSPIRE (Device) Food and Beverage In-kind items and services $20.87 General
Category: NEUROLOGY
12/18/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $26.66 General
Category: Neurology
12/14/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $23.50 General
Category: PSYCHIATRY
12/11/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $27.42 General
Category: PSYCHIATRY
11/14/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $26.72 General
Category: PSYCHIATRY
11/06/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $19.95 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
10/24/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $23.78 General
Category: NEUROSCIENCE
10/18/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $31.61 General
Category: Neurology
10/14/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $19.59 General
Category: Respiratory
10/09/2024 PFIZER INC. PAXLOVID (Drug) Food and Beverage In-kind items and services $20.90 General
Category: INFECTIOUS DISEASES
10/03/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $20.90 General
Category: Diabetes
10/02/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $34.06 General
Category: PSYCHIATRY
09/20/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $20.57 General
Category: Cardiovascular & Metabolism
09/18/2024 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $24.81 General
Category: VACCINES
09/11/2024 Dexcom, Inc. Dexcom G6 Transmitter (Medical Supply) Food and Beverage In-kind items and services $19.73 General
Category: Endocrinology
09/06/2024 Novo Nordisk Inc Food and Beverage In-kind items and services $22.13 General
09/04/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $20.48 General
Category: Respiratory
08/28/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $20.69 General
Category: Diabetes
08/23/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $24.38 General
Category: NEUROSCIENCE
08/21/2024 IRONSHORE PHARMACEUTICALS INC. JORNAY PM (Drug) Food and Beverage Cash or cash equivalent $17.43 General
Category: CENTRAL NERVOUS SYSTEM STIMULANT
08/15/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $15.72 General
Category: PSYCHIATRY
08/09/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $21.64 General
Category: PSYCHIATRY
08/08/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), TRULANCE Food and Beverage In-kind items and services $14.75 General
Category: Gastroenterology
08/07/2024 Abbott Laboratories ETERNA (Device) Food and Beverage In-kind items and services $22.29 General
Category: Neuromodulation
08/07/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $21.71 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 323 787 $106,773 $46,001
2022 8 364 750 $102,543 $42,449
2021 13 566 1,048 $130,187 $58,941
2020 13 721 1,286 $171,922 $76,010
Total Patients
1,974
Total Services
3,871
Medicare Billing
$223,401
Procedure Codes
40

All Medicare Procedures & Services

40 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 100 422 $48,029 $21,089 43.9%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Facility 2023 74 115 $17,121 $8,421 49.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 39 84 $15,000 $6,120 40.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 42 97 $12,270 $4,559 37.2%
99305 Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes Facility 2023 56 57 $11,871 $4,374 36.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 12 12 $2,482 $1,439 58.0%
99308 Follow-up nursing facility visit per day, typically 15 minutes Facility 2022 106 324 $37,520 $14,007 37.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 64 168 $20,966 $8,310 39.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 46 94 $17,086 $7,842 45.9%
99305 Initial nursing facility visit per day, typically 35 minutes Facility 2022 61 62 $13,378 $5,663 42.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 24 24 $5,160 $3,005 58.2%
99309 Follow-up nursing facility visit per day, typically 25 minutes Facility 2022 36 45 $6,966 $2,345 33.7%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2022 15 21 $1,107 $1,068 96.5%
G0444 Annual depression screening, 15 minutes Office 2022 12 12 $360.00 $210.39 58.4%
99308 Subsequent nursing facility visit, typically 15 minutes per day Facility 2021 113 331 $37,949 $16,575 43.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 66 188 $22,682 $10,303 45.4%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 64 112 $19,925 $8,095 40.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2021 41 41 $8,383 $5,136 61.3%
99305 Initial nursing facility visit, typically 35 minutes per day Facility 2021 54 56 $12,153 $4,939 40.6%
G0407 Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth Office 2021 83 142 $9,828 $4,087 41.6%
99309 Subsequent nursing facility visit, typically 25 minutes per day Facility 2021 39 57 $8,760 $3,919 44.7%
G0408 Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth Office 2021 36 44 $7,158 $3,443 48.1%
87635 Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen Office 2021 13 18 $1,122 $923.58 82.3%
90662 Vaccine for influenza for injection into muscle, split virus, preservation free Office 2021 14 14 $904.00 $896.60 99.2%
G0008 Administration of influenza virus vaccine Office 2021 17 17 $476.00 $270.13 56.8%

About Dr. Pomilla Kumar, M.D

Dr. Pomilla Kumar, M.D is a Family Medicine healthcare provider based in Bettendorf, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568431880.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pomilla Kumar, M.D has received a total of $9,924 in payments from pharmaceutical and medical device companies, with $1,103 received in 2024. These payments were reported across 618 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($9,902).

As a Medicare-enrolled provider, Kumar has provided services to 1,974 Medicare beneficiaries, totaling 3,871 services with total Medicare billing of $223,401. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Bettendorf, IA
  • Active Since 03/17/2006
  • Last Updated 03/07/2023
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1568431880

Products in Payments

  • REXULTI (Drug) $582.64
  • ENTRESTO (Drug) $452.85
  • Ozempic (Drug) $430.45
  • XARELTO (Drug) $415.70
  • BREZTRI (Drug) $344.73
  • FARXIGA (Drug) $326.18
  • VRAYLAR (Drug) $318.04
  • Victoza (Drug) $296.30
  • Kerendia (Drug) $295.35
  • UBRELVY (Drug) $277.97
  • ELIQUIS (Drug) $247.14
  • Trintellix (Drug) $217.50
  • SYMBICORT (Drug) $179.23
  • Aimovig (Biological) $178.62
  • Rybelsus (Drug) $178.37
  • PREVNAR 13 (Biological) $160.21
  • XIFAXAN (Drug) $158.34
  • TRINTELLIX (Drug) $155.74
  • VIBERZI (Drug) $142.23
  • MOUNJARO (Drug) $141.74

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Bettendorf